Malley Thomas bought KNSA
August 14, 2025 · Form 4 insider transaction
Malley Thomas bought 33,237 shares of Kiniksa Pharmaceuticals International, plc at $14.33 per share, a transaction worth $476.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,237
Price
$14.33
Total value
$476.3K
InsiderMalley Thomas
RoleDirector
SecurityClass A Ordinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 14, 2025
Filing dateAugust 14, 2025
Shares owned after64,543
OwnershipDirect
10b5-1 planNo
AmendedNo